Skip to main content
. 2015 Sep 10;10:5739–5750. doi: 10.2147/IJN.S82586

Figure 7.

Figure 7

The morphological changes of HepG2 cells, HT29 cells, MDD-MB231 cells, Chang cells, and HUVECs treated with iron–manganese-promoted sulfated zirconia nanoparticles at their respective IC50 concentrations for 72 hours..

Abbreviations: HUVEC, human umbilical vein endothelial cell; IC50, concentration of drug needed to inhibit cell growth by 50%; NPs, nanoparticles.